Fixed dose combination emtricitabine/tenofovir/efavirenz initiated during Acute HIV Infection; 96-week efficacy and durability

OBJECTIVE: Demonstrate rapid initiation of co-formulated treatment during acute HIV infection (AHI) is feasible and efficacious. DESIGN: Prospective, single-arm open label study of once daily emtricitabine/tenofovir/efavirenz initiated during AHI. METHODS: We provide final data through week 96-week...

詳細記述

保存先:
書誌詳細
出版年:AIDS
主要な著者: GAY, Cynthia L., WILLIS, Sarah J., COPE, Anna B., KURUC, JoAnn D., MCGEE, Kara S., SEBASTIAN, Joe, CROOKS, Amanda M., MCKELLAR, Mehri S., MARGOLIS, David M., FISCUS, Susan A., HICKS, Charles B., FERRARI, Guido, ERON, Joseph J.
フォーマット: Artigo
言語:Inglês
出版事項: 2016
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5101138/
https://ncbi.nlm.nih.gov/pubmed/27662549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001255
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料